|
Volumn 32, Issue 3, 2005, Pages 339-341
|
Is whole-body FDG-PET valuable for health screening?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
BLADDER CANCER;
BREAST CANCER;
CANCER DIAGNOSIS;
CANCER SCREENING;
COLON CANCER;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC PROCEDURE;
ESOPHAGUS CANCER;
HUMAN;
INTERMETHOD COMPARISON;
JAPAN;
KIDNEY CANCER;
LIVER METASTASIS;
LUNG CANCER;
LYMPHOMA;
MASS SCREENING;
OVARY CANCER;
PANCREAS CANCER;
POSITRON EMISSION TOMOGRAPHY;
PROSTATE CANCER;
REVIEW;
SEX DIFFERENCE;
STOMACH CANCER;
THYROID CANCER;
UTERINE CERVIX CANCER;
UTERUS CANCER;
WHOLE BODY SCINTISCANNING;
|
EID: 17644386849
PISSN: 16197070
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-005-1774-3 Document Type: Review |
Times cited : (38)
|
References (0)
|